구독하기
연구 모델
서비스
전임상 효능 평가
Resource
SD-huNPR1 Rat
제품 견적 요청
카탈로그에서 제품을 선택하여 요청을 제출해 주세요. Cyagen 팀이 상세 정보를 제공해 드립니다.
SD-huNPR1 Rat
제품명
SD-huNPR1 Rat
제품 ID
CR010
품종 계통
SD-Npr1em1(hNPR1)/Cya
Backgroud
Sprague-Dawley
상태
이 마우스 계통을 논문에서 사용할 경우, “SD-huNPR1 Rat (카탈로그 번호 CR010)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
HUGO-GT Humanized Models
Rat
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
가격 문의
HUGO-GT Humanized Models
Rat
기본 정보
관련 자료
기본 정보
유전자명
유전자 별칭
ANPa, NPRA, ANPRA, GUC2A, GUCY2A
NCBI ID
염색체
Chr 1
MGI ID
Datasheet
품종 계통 설명
The human NPR1 gene, also known as natriuretic peptide receptor 1 or guanylyl cyclase-A (GC-A), encodes for a transmembrane receptor called natriuretic peptide receptor-A (NPRA). This protein acts as a cell-surface receptor for atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), two key hormones that regulate cardiovascular homeostasis [1]. Upon binding, NPRA catalyzes the conversion of GTP to the second messenger cyclic GMP (cGMP), leading to vasodilation, natriuresis (increased sodium excretion), diuresis (increased urine production), and protection against cardiac remodeling [1-2]. The NPR1 gene is expressed in various cellular tissues, including the heart, kidneys, vascular smooth muscle, and immune cells. Genetic variations and altered expression of NPR1 are associated with several cardiovascular diseases, including essential hypertension, left ventricular hypertrophy, congestive heart failure, and coronary artery disease [3]. Alterations in NPRA expression have also been linked to certain cancers, such as gastric cancer, and metabolic disorders [4].
SD-huNPR1 rats are a humanized model generated using gene editing technology, in which the rat Npr1 endogenous extracellular domain is replaced with the human NPR1 extracellular domain. SD-huNPR1 rats can be used for studying the pathological mechanisms and therapeutic approaches for several cardiovascular diseases, including essential hypertension, left ventricular hypertrophy, congestive heart failure, and coronary artery disease, as well as specific cancers. They are also useful for the development of NPR1-targeted drugs.
Reference
Misono KS, Philo JS, Arakawa T, Ogata CM, Qiu Y, Ogawa H, Young HS. Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase. FEBS J. 2011 Jun;278(11):1818-29.
Hubers SA, Schirger JA, Sangaralingham SJ, Chen Y, Burnett JC Jr, Hodge D, Chen HH. B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial. Heart. 2021 Mar;107(5):396-402.
Vandenwijngaert S, Ledsky CD, Lahrouchi N, Khan MAF, Wunderer F, Ames L, Honda T, Diener JL, Bezzina CR, Buys ES, Bloch DB, Newton-Cheh C; CHARGE+ Exome Chip Blood Pressure Consortium, the CHD Exome+ Consortium, the Exome BP Consortium, the GoT2D Consortium, the T2D-GENES Consortium and the UK Biobank CardioMetabolic Consortium BP Working Group. Blood Pressure-Associated Genetic Variants in the Natriuretic Peptide Receptor 1 Gene Modulate Guanylate Cyclase Activity. Circ Genom Precis Med. 2019 Aug;12(8):e002472.
Cao T, Wang S, Qian L, Wu C, Huang T, Wang Y, Li Q, Wang J, Xia Y, Xu L, Wang L, Huang X. NPRA promotes fatty acid metabolism and proliferation of gastric cancer cells by binding to PPARα. Transl Oncol. 2023 Sep;35:101734.
변형 전략

Figure 1. Gene editing strategy for SD-huNPR1 rats. The rat Npr1 endogenous extracellular domain was replaced with the human NPR1 extracellular domain.
응용 분야
NPR1-targeted drug screening, development, and evaluation;
Research on the pathological mechanisms and therapeutic approaches of several cardiovascular diseases, including essential hypertension, left ventricular hypertrophy, congestive heart failure, and coronary artery disease;
Research on the pathological mechanisms and therapeutic approaches of specific cancers.
관련 자료
문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
